ELVN:NASDAQ
Enliven Therapeutics Inc
$46.85
arrow_downward
-1.62%(-0.77) 1D
$46.85
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 17, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ELVN...
Open
$47.61
High
$47.75
Low
$46.05
Mkt. cap
3.45B
Avg. vol.
1.49M
Volume
652.27K
52-wk high
$62.32
52-wk low
$14.78
EPS
-$1.70
Beta
0.34
Shares outstanding
73.60M
No. of employees
65
Open
$47.61
High
$47.75
Low
$46.05
Mkt. cap
3.45B
Avg. vol.
1.49M
Volume
652.27K
52-wk high
$62.32
52-wk low
$14.78
EPS
-$1.70
Beta
0.34
Shares outstanding
73.60M
No. of employees
65
News stories
From web sources and news partners
TradingView
·
9 hours ago
ELVN: Second-line-plus phase III launch is imminent, with a potential early-2029 readout
About Enliven Therapeutics Inc
CEO-
Employees65
Founded2016
HeadquartersBoulder, Colorado, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteimaratx.com